Clinical Trials
4
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Safety & Immunogenicity of Booster SARS-CoV-2 Vaccine (Vero Cell)
- Conditions
- COVID-19
- First Posted Date
- 2021-12-29
- Last Posted Date
- 2022-09-08
- Lead Sponsor
- PT. Kimia Farma (Persero) Tbk
- Target Recruit Count
- 600
- Registration Number
- NCT05172193
- Locations
- 🇮🇩
Universitas Udayana Hospital, Badung, Bali, Indonesia
🇮🇩Bali Mandara Hospital, Denpasar, Bali, Indonesia
🇮🇩Kimia Farma Soetomo Clinic and Laboratorium, Semarang, Central Java, Indonesia
The Immunogenicity, Safety, and Effectiveness of the COVID-19 Inactivated Vaccine
- Conditions
- COVID-19
- First Posted Date
- 2021-11-19
- Last Posted Date
- 2022-09-08
- Lead Sponsor
- PT. Kimia Farma (Persero) Tbk
- Target Recruit Count
- 435
- Registration Number
- NCT05126550
- Locations
- 🇮🇩
Laboratorium Klinik Kimia Farma Diponegoro Bandung, Bandung, Indonesia
🇮🇩Laboratorium Klinik Kimia Farma Cikini, Jakarta, Indonesia
🇮🇩Laboratorium Klinik Kimia Farma Medan, Medan, Indonesia
Pharmacokinetic Properties of 200 and 400 mg Acyclovir Tablet in Indonesia Healthy Subject
- Conditions
- Drug Use
- Interventions
- First Posted Date
- 2021-08-03
- Last Posted Date
- 2023-02-09
- Lead Sponsor
- PT. Kimia Farma (Persero) Tbk
- Target Recruit Count
- 56
- Registration Number
- NCT04988646
- Locations
- 🇮🇩
PT Pharma Metric Labs, Jakarta Pusat, DKI Jakarta, Indonesia
Bioequivalence Study of Furosemide 40 mg Tablet in 24 Indonesian Healthy Volunteers
- Conditions
- Drug Use
- Interventions
- First Posted Date
- 2021-07-29
- Last Posted Date
- 2023-11-02
- Lead Sponsor
- PT. Kimia Farma (Persero) Tbk
- Target Recruit Count
- 24
- Registration Number
- NCT04982874
- Locations
- 🇮🇩
PT Pharma Metric Labs, Jakarta Pusat, DKI Jakarta, Indonesia